Researcher Paolo Paoletti now heads cancer drug development at GlaxoSmithKline.

FORBES: Icahn Wins, But Bristol Isn't A Total Loser Either

Until now, OSI had only one major drug in development: Tarceva, a cancer drug that it is developing with Roche and Genentech (nyse: DNA - news - people ).

FORBES: For Drug Deals, Think Small

Chief Executive StanleyCrookeStanley Crooke, 60, headed drug development at Smithkline Beckman and anti-cancer research at Bristol-Myers Squibb.

FORBES

The drug, developed through Cancer Research UK's Clinical Development Partnerships (CDP), starves cancer cells of the sugars they need to grow and develop.

BBC: Sir Bobby Robson and Ruth Plummer

Chief Executive Stanley Crooke , 60, headed drug development at Smithkline Beckman and anti-cancer research at Bristol-Myers Squibb (nyse: BMY - news - people ).

FORBES: Cholesterol Comeback

Therapeutic cancer vaccines, which train immune cells to attack cancer cells, are one of the most enticing areas of drug development.

FORBES: Immune Cells Attacking Tumors, An iPad Under A Microscope, And The Medical Side Effects Of Spanx

They already have contributed to the development of the antibiotics erythromycin and tetracycline, the cancer chemotherapy drug doxorubicin, Wyeth's transplant drug Rapamune, and Merck's cholesterol-lowering medicine, Mevacor.

FORBES: A Dirty Business

She said the findings were not just important for drug development, but also for developing a test which can predict the likelihood of cancer spreading and as a result, patient outcomes.

BBC: Blocking enzyme cut cancer spread

Apart from its anti-cancer drugs Fusilev and Zevalin, Spectrum has 10 other oncology drug candidates that are now in clinical development, two of them in phase 3 clinical trials and several undergoing phase 1 and 2 clinical studies.

FORBES: Why This Tiny But Profitable Biotech May Be Gobbled Up By Big Pharma

Charles Baum, who heads Pfizer's oncology development program, says cancer drugs now account for 20% of the money Pfizer is spending on drug testing.

FORBES: Magazine Article